This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Tice AD, Turpin RS, Hoey CT, Lipsky BA, Wu J, Abramson MA.Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections. American Journal of Health-System Pharmacy 64: 1080-1086, No. 10, 15 May 2007
Rights and permissions
About this article
Cite this article
Ertapenem less costly than piperacillin/tazobactam in foot infections. Pharmacoecon. Outcomes News 532, 6 (2007). https://doi.org/10.2165/00151234-200705320-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705320-00011